If AGN would 'have' to divest…Enox program, and I see no reason why…
The why is that AGN’s not divesting would result in TEVA’s owning AGN’s Lovenox rights as well as TEVA’s own version of generic Lovenox, which is clearly anticompetitive.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”